QuidelOrtho Corporation
QDEL
$33.46
$0.431.30%
NASDAQ
03/30/2025 | 12/29/2024 | 09/29/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 692.80M | 707.80M | 727.10M | 637.00M | 711.00M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 692.80M | 707.80M | 727.10M | 637.00M | 711.00M |
Cost of Revenue | 349.50M | 381.70M | 374.80M | 361.00M | 378.90M |
Gross Profit | 343.30M | 326.10M | 352.30M | 276.00M | 332.10M |
SG&A Expenses | 187.00M | 187.50M | 186.40M | 188.20M | 204.70M |
Depreciation & Amortization | 48.00M | 47.90M | 51.90M | 51.90M | 51.70M |
Other Operating Expenses | 6.40M | -3.60M | 6.30M | 9.30M | 8.00M |
Total Operating Expenses | 644.10M | 660.80M | 675.30M | 666.70M | 702.50M |
Operating Income | 48.70M | 47.00M | 51.80M | -29.70M | 8.50M |
Income Before Tax | -8.80M | -140.90M | -28.80M | -162.90M | -1.80B |
Income Tax Expenses | 3.90M | 37.50M | -8.90M | -15.20M | -92.90M |
Earnings from Continuing Operations | -12.70M | -178.40M | -19.90M | -147.70M | -1.71B |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -12.70M | -178.40M | -19.90M | -147.70M | -1.71B |
EBIT | 48.70M | 47.00M | 51.80M | -29.70M | 8.50M |
EBITDA | 155.80M | 153.60M | 164.90M | 86.40M | 123.40M |
EPS Basic | -0.19 | -2.65 | -0.30 | -2.20 | -25.50 |
Normalized Basic EPS | 0.07 | 0.06 | 0.07 | -0.70 | -0.30 |
EPS Diluted | -0.19 | -2.66 | -0.30 | -2.20 | -25.50 |
Normalized Diluted EPS | 0.07 | 0.06 | 0.07 | -0.70 | -0.30 |
Average Basic Shares Outstanding | 67.50M | 67.30M | 67.30M | 67.10M | 66.90M |
Average Diluted Shares Outstanding | 67.50M | 67.30M | 67.30M | 67.10M | 66.90M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |